These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 3823487)

  • 1. Effects of thromboxane analog U46619 on endothelial damaged canine coronary arteries in vivo.
    Bove AA; Safford RE; Brum JM; Sufan Q; Dewey JD
    Prostaglandins; 1986 Nov; 32(5):665-77. PubMed ID: 3823487
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The thromboxane A2 mimetic U46619 worsens canine myocardial hypoperfusion during exercise in the presence of a coronary artery stenosis.
    Bache RJ; Dai XZ
    Cardiovasc Res; 1992 Apr; 26(4):351-6. PubMed ID: 1638566
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of endothelium-derived relaxing factor and prostaglandins in responses of coronary arteries to thromboxane in vivo.
    Szwajkun K; Lamping KG; Dole WP
    Circ Res; 1990 Jun; 66(6):1729-37. PubMed ID: 2344671
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Endogenous adenosine and coronary vasoconstriction in hypoperfused myocardium during exercise.
    Duncker DJ; Laxson DD; Lindstrom P; Bache RJ
    Cardiovasc Res; 1993 Sep; 27(9):1592-7. PubMed ID: 8287435
    [TBL] [Abstract][Full Text] [Related]  

  • 5. K+ channel-opening action contributes to the preventive effects of nicorandil on U46619-induced vasoconstriction of canine large coronary arteries in vivo.
    Kamijo T; Iwai T; Haruta K; Takeda K
    Arch Int Pharmacodyn Ther; 1996; 331(3):273-84. PubMed ID: 9124999
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of hypoxia on contraction and 45Ca2+ uptake induced by the thromboxane mimetic U46619 in sheep coronary artery.
    Dalen T; Vestereng M; Wadsworth R; Kane K
    Eur J Pharmacol; 1994 Aug; 270(4):313-9. PubMed ID: 7805780
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of gender and sex steroids on the contractile response of canine coronary and renal blood vessels.
    Karanian JW; Ramwell PW
    J Cardiovasc Pharmacol; 1996 Mar; 27(3):312-9. PubMed ID: 8907791
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The vasoactive effect of serotonin on canine coronary arteries after ischemia and reperfusion.
    Sheridan FM
    Coron Artery Dis; 1994 Jun; 5(6):481-6. PubMed ID: 7952406
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of cyclic flow variations in stenosed canine coronary arteries by thromboxane A2/prostaglandin H2 receptor antagonists.
    Ashton JH; Schmitz JM; Campbell WB; Ogletree ML; Raheja S; Taylor AL; Fitzgerald C; Buja LM; Willerson JT
    Circ Res; 1986 Nov; 59(5):568-78. PubMed ID: 3542279
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Attenuation of coronary flow reserve and myocardial function after temporary subtotal coronary artery occlusion and increased myocardial oxygen demand in dogs.
    Nichols WW; Nicolini FA; Yang B; Robbins WC; Katopodis J; Chen L; Saldeen TG; Mehta JL
    J Am Coll Cardiol; 1994 Sep; 24(3):795-803. PubMed ID: 8077555
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chronic cocaine treatment enhances the responsiveness of the left anterior descending coronary artery and the femoral artery to vasoactive substances.
    Jones LF; Tackett RL
    J Pharmacol Exp Ther; 1990 Dec; 255(3):1366-70. PubMed ID: 2262907
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of U46619 on contractions to 5-HT, sumatriptan and methysergide in canine coronary artery and saphenous vein in vitro.
    Kemp BK; Cocks TM
    Br J Pharmacol; 1995 Oct; 116(4):2183-90. PubMed ID: 8564247
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Novel angiotensin II AT(1) receptor antagonist irbesartan prevents thromboxane A(2)-induced vasoconstriction in canine coronary arteries and human platelet aggregation.
    Li P; Fukuhara M; Diz DI; Ferrario CM; Brosnihan KB
    J Pharmacol Exp Ther; 2000 Jan; 292(1):238-46. PubMed ID: 10604953
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of endogenous prostacyclin in myocardial blood flow regulation distal to a severe coronary stenosis.
    Ruocco NA; Most AS; Sasken H; Steiner M; Gewirtz H
    Cardiovasc Res; 1988 Jul; 22(7):511-9. PubMed ID: 3075513
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interaction of epoprostenol (PGI2) with vasoconstrictors on diameter of large coronary arteries of the dog.
    Dusting GJ; Angus JA
    J Cardiovasc Pharmacol; 1984; 6(1):20-7. PubMed ID: 6199604
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Augmented contraction of the human isolated coronary artery by sumatriptan: a possible role for endogenous thromboxane.
    Maassen VanDenBrink A; Bax WA; Ferrari MD; Zijlstra FJ; Bos E; Saxena PR
    Br J Pharmacol; 1996 Nov; 119(5):855-62. PubMed ID: 8922732
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of eicosanoid-mediated coronary constriction during myocardial ischemia.
    Laurindo FR; Finton CK; Ezra D; Czaja JF; Feuerstein GZ; Goldstein RE
    FASEB J; 1988 Jun; 2(9):2479-86. PubMed ID: 3371592
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term estradiol replacement decreases contractility of guinea pig coronary arteries to the thromboxane mimetic U46619.
    Thompson LP; Weiner CP
    Circulation; 1997 Feb; 95(3):709-14. PubMed ID: 9024161
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Coronary artery constriction by the isoprostane 8-epi prostaglandin F2 alpha.
    Kromer BM; Tippins JR
    Br J Pharmacol; 1996 Nov; 119(6):1276-80. PubMed ID: 8937734
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of contractile responses to 5-hydroxytryptamine and sumatriptan in human isolated coronary artery: synergy with the thromboxane A2-receptor agonist, U46619.
    Cocks TM; Kemp BK; Pruneau D; Angus JA
    Br J Pharmacol; 1993 Sep; 110(1):360-8. PubMed ID: 8220898
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.